Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNYNF) Change in Cash (2019 - 2025)

Historic Change in Cash for Sanofi (SNYNF) over the last 7 years, with Q4 2025 value amounting to -$10.7 billion.

  • Sanofi's Change in Cash fell 68697.52% to -$10.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$40.3 million, marking a year-over-year increase of 9948.0%. This contributed to the annual value of $244.1 million for FY2025, which is 11777.24% up from last year.
  • As of Q4 2025, Sanofi's Change in Cash stood at -$10.7 billion, which was down 68697.52% from $1.7 billion recorded in Q3 2025.
  • In the past 5 years, Sanofi's Change in Cash registered a high of $8.3 billion during Q2 2025, and its lowest value of -$10.7 billion during Q4 2025.
  • In the last 4 years, Sanofi's Change in Cash had a median value of $11.8 million in 2021 and averaged -$863.8 million.
  • As far as peak fluctuations go, Sanofi's Change in Cash skyrocketed by 978258.26% in 2021, and later tumbled by 68697.52% in 2025.
  • Quarter analysis of 4 years shows Sanofi's Change in Cash stood at $11.8 million in 2021, then tumbled by 36862.88% to -$4.3 billion in 2023, then soared by 68.7% to -$1.4 billion in 2024, then plummeted by 686.98% to -$10.7 billion in 2025.
  • Its Change in Cash was -$10.7 billion in Q4 2025, compared to $1.7 billion in Q3 2025 and $8.3 billion in Q2 2025.